Literature DB >> 2172231

Chimeric alpha- and beta-platelet-derived growth factor (PDGF) receptors define three immunoglobulin-like domains of the alpha-PDGF receptor that determine PDGF-AA binding specificity.

M A Heidaran1, J H Pierce, R A Jensen, T Matsui, S A Aaronson.   

Abstract

Binding of platelet-derived growth factor (PDGF) to its cell surface receptors stimulates a variety of biochemical and biological responses. Two receptor gene products (designated alpha and beta) have been identified, and the different binding affinities of various PDGF isoforms for these receptors are prime determinants of the spectrum of responses observed. The beta receptor binds PDGF-BB, but not PDGF-AA, while the alpha receptor binds PDGF-AA and PDGF-BB. We utilized these different ligand binding specificities to investigate the PDGF-AA binding site in the human alpha-PDGF receptor by constructing chimeric molecules between the human alpha- and beta-PDGF receptors. Our results demonstrate that amino acids 1-340 of the alpha-PDGF receptor comprise the region that confers PDGF-AA binding specificity. This region corresponds to immunoglobulin-like sub-domains 1, 2, and 3 of its external domain.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2172231

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  The N-terminal globular domain of Eph receptors is sufficient for ligand binding and receptor signaling.

Authors:  J P Labrador; R Brambilla; R Klein
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

2.  Redox regulation of epidermal growth factor receptor signaling during the development of pulmonary hypertension.

Authors:  Olga Rafikova; Ruslan Rafikov; Archana Kangath; Ning Qu; Saurabh Aggarwal; Shruti Sharma; Julin Desai; Taylor Fields; Britta Ludewig; Jason X-Y Yuan; Danny Jonigk; Stephen M Black
Journal:  Free Radic Biol Med       Date:  2016-02-27       Impact factor: 7.376

3.  Physical interaction of CCN2 with diverse growth factors involved in chondrocyte differentiation during endochondral ossification.

Authors:  Hany Mohamed Khattab; Eriko Aoyama; Satoshi Kubota; Masaharu Takigawa
Journal:  J Cell Commun Signal       Date:  2015-04-19       Impact factor: 5.782

4.  The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade.

Authors:  T Davis-Smyth; H Chen; J Park; L G Presta; N Ferrara
Journal:  EMBO J       Date:  1996-09-16       Impact factor: 11.598

Review 5.  Structural and functional properties of platelet-derived growth factor and stem cell factor receptors.

Authors:  Carl-Henrik Heldin; Johan Lennartsson
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-08-01       Impact factor: 10.005

6.  Genomic structure of the human KDR/flk-1 gene.

Authors:  L Y Yin; Y Wu; C A Ballinger; C Patterson
Journal:  Mamm Genome       Date:  1998-05       Impact factor: 2.957

7.  Structure of the active core of human stem cell factor and analysis of binding to its receptor kit.

Authors:  X Jiang; O Gurel; E A Mendiaz; G W Stearns; C L Clogston; H S Lu; T D Osslund; R S Syed; K E Langley; W A Hendrickson
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

8.  Identification of the ligand-binding regions in the macrophage colony-stimulating factor receptor extracellular domain.

Authors:  Z E Wang; G M Myles; C S Brandt; M N Lioubin; L Rohrschneider
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

9.  Effects of mesenchymal stem cells and VEGF on liver regeneration following major resection.

Authors:  Gokhan Adas; Bora Koc; Mine Adas; Gokhan Duruksu; Cansu Subasi; Ozgur Kemik; Ahu Kemik; Damlanur Sakiz; Mustafa Kalayci; Sevim Purisa; Seda Unal; Erdal Karaoz
Journal:  Langenbecks Arch Surg       Date:  2016-04-19       Impact factor: 3.445

10.  Mutational analysis of the beta-type platelet-derived growth factor receptor defines the site of interaction with the bovine papillomavirus type 1 E5 transforming protein.

Authors:  A Staebler; J H Pierce; S Brazinski; M A Heidaran; W Li; R Schlegel; D J Goldstein
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.